Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report.

Liu, Zhongan; Hu, Feng; Guo, Shuang; Zhang, Peng; Li, Guiling; Qin, You

Liu, Zhongan; Hu, Feng; Guo, Shuang; Zhang, Peng; Li, Guiling; Qin, You.

Afiliación

Liu Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Hu F; Department of Dermatology, Wuhan No. 1 Hospital, Wuhan 430022, China.
Guo S; Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhang P; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Li G; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Qin Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Open Life Sci ; 18(1): 20220672, 2023.

Article en En | MEDLINE | ID: mdl-38035045

Palabras clave

necrolytic migratory erythema; pancreatic neuroendocrine tumors; surufatinib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Life Sci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google